Bacillus subtilis genome in-situ integrated spore surface display vector and application thereof
Through the in situ integrated spore surface display vector pHY1.0 of Bacillus subtilis genome, the problem of low display efficiency in the prior art is solved, and the effect of simultaneously displaying multiple exogenous protein molecules on the surface of Bacillus subtilis is improved. The development and production value of multivalent vaccines.
Patent Information
- Application Number
- CN202310591091.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-24
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, the surface display efficiency of Bacillus subtilis spores is low, especially in ectopic integration methods. The surface display efficiency of exogenous proteins is low, and multiple exogenous protein molecules cannot be displayed simultaneously, which limits its use in multivalent vaccines. Application in development.
The in situ integrated spore surface display vector pHY1.0 is used to display Bacillus subtilis genome in situ integrated spore surface. This vector contains CotW, CotX, CotY and CotZ encoding genes, which can display multiple identical or different exogenous protein molecules at the same time, through the spore capsid protein Fusion method displays exogenous proteins on the surface of spores.
It significantly improves the display efficiency of exogenous protein molecules and can display multiple exogenous protein molecules on the surface of each spore at the same time, enhancing its application value in the development and production of multivalent vaccines.
Smart Images

Figure CN119020388A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biotechnology, and specifically relates to a new Bacillus subtilis genome in situ integrated spore surface display vector and its application, and in particular to a Bacillus subtilis genome in situ integrated spore surface display vector capable of simultaneously displaying a plurality of identical or different exogenous protein molecules and its application, and in particular to its application in the field of multivalent vaccine research. Background Art
[0002] Bacillus subtilis is a Gram-positive probiotic that has long been used in the production of food additives and industrial enzyme preparations. Bacillus subtilis spores are stable, resistant to stress, and safe. Displaying foreign proteins on the surface of Bacillus subtilis spores and establishing a spore surface display system for foreign proteins will help develop new vaccines for needle-free immunization.
[0003] CotB, CotC, CotD, CotX, CotY and CotZ and other spore outer shell proteins (hereinafter referred to as shell proteins or capsid proteins) as anchor proteins can not only display proteins with larger molecular weight, but also do not need to penetrate the membrane during the protein surface display process, which helps to improve the folding and display efficiency of foreign proteins, and is often used to construct Bacillus subtilis spore surface display carriers. For example, patent document CN105132450A (hereinafter referred to as document 1) discloses a method for displaying trehalose synthase on the surface of Bacillus subtilis spore capsid protein Cot, which uses Cot series spore capsid proteins (such as CotG, CotB, CotC, CotD, CotH, CotX, CotY and CotZ) as molecular carriers for displaying foreign proteins on the spore surface, and can display trehalose synthase on the spore surface, without antibacterial activity, meeting the requirements of food application enzyme preparations, and is conducive to the production and manufacturing of trehalose in the next step. However, from the method disclosed in the document 1, it is to use the Escherichia coli-Bacillus subtilis shuttle plasmid pHT01 to express the Cot-trehalose synthase fusion protein in the cytoplasm of Bacillus subtilis, and it is hoped that the fusion protein expressed in the cytoplasm can be displayed on the surface of the subtilis spores when the spores are formed, but the results show that the surface display efficiency is very low, and the maximum enzyme activity displayed on the spore surface is only 0.63U / ml (with CotG as the molecular vector), which lacks practical application value. The main reason is that the method disclosed in the document 1 belongs to an ectopic integration method, and the Cot fusion protein expressed by its vector can only be randomly incorporated into the spore capsid when the spore capsid is formed, so the efficiency of display on the spore surface is low. Patent document CN101693900A (hereinafter referred to as document 2) discloses an application of Bacillus subtilis spore capsid protein CotX as a spore display foreign protein molecular carrier, which carries out genetic recombination of the coding gene CotX of the carrier protein with the coding sequence of the foreign protein gene, constructs an integrated recombinant plasmid that fusion expresses the recombinant protein, transforms Bacillus subtilis, screens the recombinant strain, induces the recombinant strain to produce spores, and obtains recombinant spores that display the foreign target protein on the surface. From the method disclosed in document 2, the integrated recombinant plasmid pBS16 ectopically integrates the CotX-foreign protein fusion gene into the amylase E gene (AmyE) of the Bacillus subtilis genome, expresses the CotX fusion protein and displays it on the surface of the subtilis spores. The CotX fusion protein expressed by this ectopic integration vector can only be displayed on the surface of the subtilis spores in a random incorporation manner when the spore capsid is formed, as in the above-mentioned document 1, and the spore surface display efficiency is still very low.Yang Yawei et al. attempted to use the in situ integration method to construct an in situ integrated subtilis spore surface vector pEYW26 with CotZ as a molecular carrier (Yang Yawei et al., Construction of in situ integrated Bacillus subtilis spore surface display vector, Journal of Animal Ecology, Vol. 39, No. 10, October 2018, hereinafter referred to as Document 3), proving that in situ integration as a new surface display method can be applied to Bacillus subtilis spore surface display, which can improve the spore surface display efficiency compared to the ectopic integration method. However, the spore surface display vector disclosed in Document 3 can only display one exogenous protein molecule on each spore surface, which limits its application in the development of multivalent vaccines, and the surface display efficiency is still low (as shown in Document 3, less fluorescence can be observed under a fluorescence microscope). Summary of the invention
[0004] In view of one or more problems existing in the prior art, the present invention provides a Bacillus subtilis genome in situ integrated spore surface display vector pHY1.0, and each recombinant spore constructed using the vector can display multiple exogenous protein molecules simultaneously.
[0005] The in situ integrated spore surface display vector pHY1.0 provided by the present invention comprises CotW, CotX, CotY and CotZ encoding genes, and is capable of simultaneously displaying multiple exogenous protein molecules, wherein the multiple exogenous protein molecules are the same or different;
[0006] In the in situ integrated spore surface display vector pHY1.0, the 5' end of the CotX encoding gene contains a first promoter, and the 5' end of the CotZ encoding gene contains a second promoter;
[0007] In the in situ integrated spore surface display vector pHY1.0, the CotW encoding gene is used for homologous recombination with the corresponding sequence in the Bacillus subtilis genome, and the CotX, CotY and CotZ encoding genes are used as vectors of the encoding genes of foreign protein molecules.
[0008] In some embodiments, the first promoter and the second promoter are identical in sequence, and are both natural promoters of the CotX, CotY and CotZ encoding genes in the genome sequence of Bacillus subtilis.
[0009] In some embodiments, the in situ integrated spore surface display vector pHY1.0 further includes a pBR322 backbone, a chloramphenicol resistance gene, and a penicillin resistance gene.
[0010] In some embodiments, the 3' end of the CotW encoding gene is connected to the 5' end of the CotX encoding gene, the 3' end of the CotX encoding gene is directly connected to the 5' end of the CotY encoding gene or indirectly connected through a first multiple cloning site, the 3' end of the CotY encoding gene is separated from the 5' end of the CotZ encoding gene by an optional second multiple cloning site, a partial backbone sequence and a chloramphenicol resistance gene, and the 3' end of the CotZ encoding gene is connected to an optional third multiple cloning site, and a sequence including a sequence for homologous recombination with a corresponding sequence in the genome of Bacillus subtilis, a plasmid replication initiation sequence and a penicillin resistance gene, wherein the first multiple cloning site, the second multiple cloning site and the third multiple cloning site sequences are the same or different.
[0011] In some embodiments, the in situ integrated spore surface display vector pHY1.0 contains one of the following nucleotide sequences:
[0013] 1) the nucleotide sequence shown in SEQ ID NO: 1;
[0014] 2) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 1 and having the function of in situ integration of the CotW / X / Y / Z gene in the Bacillus subtilis genome;
[0015] 3) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing under highly stringent conditions; the highly stringent conditions are washing the membrane with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization;
[0016] 4) the nucleotide sequence shown in SEQ ID NO: 2;
[0017] 5) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 2 and having the function of in situ integration of CotW / X / Y / Z gene in the Bacillus subtilis genome;
[0018] 6) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 2 in the sequence listing under highly stringent conditions; the highly stringent conditions are washing the membrane with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0019] In some embodiments, the exogenous protein molecule is selected from: Vibrio vulnificus flagellin B (FlaB), heat-labile enterotoxin B subunit (LTB), Vibrio cholerae toxin B subunit (CTB), Helicobacter pylori urease B, Helicobacter pylori heat shock protein A, Helicobacter pylori vacuolating toxin A, Helicobacter pylori adhesin A, Clostridium difficile toxin A, Clostridium difficile toxin B, and their fusion proteins.
[0020] In some embodiments, the exogenous protein molecule is a fusion protein of FlaB, LTB and CTB, named as exogenous protein FlaB+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing; 2) an amino acid residue sequence in which the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing is substituted, deleted or added with one to ten amino acid residues and has immune adjuvant activity.
[0021] In some embodiments, the nucleotide sequence of the gene encoding the exogenous protein FlaB+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 3 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing and encodes an immune adjuvant molecule; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing under highly stringent conditions.
[0022] In some embodiments, the exogenous protein molecule is a fusion protein of Helicobacter pylori urease B, heat shock protein A and LTB, named exogenous protein UrB+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing; 2) an amino acid residue sequence in which the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing is substituted, deleted or added with one to ten amino acid residues and has antigenic activity.
[0023] In some embodiments, the nucleotide sequence of the gene encoding the exogenous protein UrB+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 5 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing under highly stringent conditions.
[0024] In some embodiments, the exogenous protein molecule is a fusion protein of Helicobacter pylori vacuolating toxin A, adhesin A and LTB, named as exogenous protein VacA+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing; 2) an amino acid residue sequence in which the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing is substituted, deleted or added with one to ten amino acid residues and has antigenic activity.
[0025] In some embodiments, the nucleotide sequence of the gene encoding the exogenous protein VacA+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 7 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing under highly stringent conditions.
[0026] In some embodiments, the exogenous protein molecule is a fusion protein of FlaB, Clostridium difficile toxin A and LTB, named as exogenous protein CdTA+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing; 2) an amino acid residue sequence in which the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing is substituted, deleted or added with one to ten amino acid residues and has antigenic activity.
[0027] In some embodiments, the nucleotide sequence of the gene encoding the exogenous protein CdTA+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 10 in the sequence list; 2) the nucleotide sequence encoding SEQ ID NO: 9 in the sequence list; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence list and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence list under highly stringent conditions.
[0028] The use of the in situ integrated spore surface display vector pHY1.0 provided by the present invention in the development or production of multivalent vaccines also belongs to the content of the present invention.
[0029] The Bacillus subtilis genome in situ integrated spore surface display vector pHY1.0 provided based on the above technical solution uses pBR322 as a backbone vector, contains CotW, CotX, CotY and CotZ coding genes, and contains a promoter at the 5' end of the CotX coding gene for initiating the expression of the CotX and CotY coding genes, and inserts another promoter at the 5' end of the CotZ coding gene for enhancing the expression of the CotZ coding gene. When displaying foreign protein molecules, the coding gene of the foreign protein molecule can be connected to the 3' end of one, two or three of the CotX, CotY and CotZ coding genes of the vector pHY1.0, and displayed on the Bacillus subtilis spores in the form of a fusion protein with the capsid protein (CotX, CotY and / or CotZ). The surface of the spore particles of bacteria, relative to the ectopic integration type vectors disclosed in the above-mentioned documents 1 and 2, the in situ integration type spore surface display vector pHY1.0 provided by the present invention can significantly improve the display efficiency of foreign protein molecules, and relative to the in situ integration type vector disclosed in the above-mentioned document 3, which can only display one foreign protein molecule on each spore surface, the in situ integration type spore surface display vector pHY1.0 provided by the present invention can simultaneously display multiple (for example, two or three) identical or different foreign protein molecules on each spore surface, wherein when multiple different foreign protein molecules are displayed simultaneously, the vector pHY1.0 provided by the present invention can be applied to the development and production of multivalent vaccines, and when multiple identical foreign protein molecules are displayed simultaneously, the display abundance of the foreign protein molecules on the spore surface can be further significantly improved. The present invention can play an important role in the fields of medicine and biopharmaceuticals, and has broad application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Immunofluorescence detection images of exogenous protein FlaB+ displayed on the surface of pHY1.0 / FlaB+ spore particles (A) and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles (B).
[0031] Figure 2 This is an immunofluorescence detection image of the exogenous protein UrB+ displayed on the surface of pHY1.0 / UrB+ spore particles.
[0032] Figure 3 This is an immunofluorescence detection image of the exogenous protein VacA+ displayed on the surface of pHY1.0 / VacA+ spore particles.
[0033] Figure 4 This is an immunofluorescence detection image of the exogenous protein CdTA+ displayed on the surface of pHY1.0 / CdTA+ spore particles.
[0034] Figure 5Immunofluorescence detection images of exogenous proteins FlaB (A), LTB (B) and CTB (C) displayed on the surface of pHY1.0 / FlaB / LTB / CTB spore particles. DETAILED DESCRIPTION
[0035] The present invention aims to provide a Bacillus subtilis genome in situ integrated spore surface display vector capable of simultaneously displaying multiple foreign protein molecules, and provides the application of the vector. The present invention is described in detail through the following aspects.
[0036] 1. The present invention provides a Bacillus subtilis genome in situ integrated spore surface display vector, named pHY1.0, which is mainly composed of a pBR322 backbone, CotW / X / Y / Z encoding genes, a chloramphenicol resistance gene and a penicillin resistance gene, wherein the CotW encoding gene is used for homologous recombination with the corresponding sequence in the Bacillus subtilis genome, which is conducive to the in situ integration of the linearized vector pHY1.0 into the corresponding position in the Bacillus subtilis genome; the CotX, CotY and CotZ encoding genes are respectively used as carriers of exogenous protein molecule encoding genes The CotW / X / Y encoding genes can be connected according to the natural sequence in the Bacillus subtilis genome, that is, the 3' end of the CotW encoding gene is connected to the 5' end of the CotX encoding gene, and the 3' end of the CotX encoding gene is connected to the 5' end of the CotY encoding gene (optionally, a first multiple cloning site is inserted between the 3' end of the CotX encoding gene and the 5' end of the CotY encoding gene, which is used to connect the encoding gene of the foreign protein to the 3' end of the CotX encoding gene by enzyme cutting), and the 5' end of the CotZ encoding gene is connected to the 5' end of the CotY encoding gene. The 3' end is not directly connected, and is separated by a partial backbone sequence of the pHY1.0 vector (the length of the partial backbone sequence is not limited) and a chloramphenicol resistance gene (optionally, a second multiple cloning site is also connected to the 3' end of the CotY encoding gene, which is used to connect the coding gene of the foreign protein to the 3' end of the CotY encoding gene by enzyme cutting). This is different from the natural sequence in the Bacillus subtilis genome (the 3' end of the CotY encoding gene is connected to the 5' end of the CotZ encoding gene), and another sequence for homologous recombination is also connected to the 3' end of the CotZ encoding gene. (which is the natural genomic sequence after the 3' end of the CotZ encoding gene in the Bacillus subtilis genome), a plasmid replication initiation sequence and a penicillin resistance gene, and a partial backbone sequence (optionally, a third multiple cloning site is also connected to the 3' end of the CotZ encoding gene for connecting the coding gene of the exogenous protein to the 3' end of the CotZ encoding gene by enzyme cleavage), wherein the sequences of the first, second and third multiple cloning sites are the same or different, and the multiple (e.g., two) single enzyme cleavage sites contained in the multiple cloning site can be selected from the enzyme cleavage sites conventionally used in the art, such as Acc I, Afl III, Asc I, Ava I, BamH I, Bgl II, BssH II, BstE II, BstX I, Cla I, EcoR I, Hae III, HindIII, Nhe I, Not I, Pac I, Sac II, Sma I, etc.The 5' end of the CotX encoding gene contains a first promoter for initiating the expression of the CotX and CotY encoding genes and their fusion proteins, and the 5' end of the CotZ encoding gene contains a second promoter (in the natural genome sequence of Bacillus subtilis, the CotX, CotY and CotZ encoding genes share a promoter, so the second promoter is a promoter newly inserted in the vector pHY1.0) for enhancing the expression of the CotZ encoding gene and its fusion protein, wherein the first promoter and the second promoter have the same sequence, and are both natural promoters of the CotX, CotY and CotZ encoding genes in the Bacillus subtilis genome. When under an environment of nutrient deficiency, the first and second promoters can be activated to initiate the expression of capsid proteins (CotX, CotY, CotZ), promote spore formation, and then display the exogenous protein molecules fused with the capsid proteins on the spore surface.
[0037] In the process of designing and constructing the vector pHY1.0 provided by the present invention, the inventors also tried the following vector structures (constructs 1-3). However, experiments have shown (the experimental methods are the same as those of Examples 1-4) that constructs 1-3 cannot simultaneously and efficiently display multiple exogenous protein molecules:
[0038] Construct 1: Compared with the above-mentioned vector pHY1.0, it lacks the CotW coding gene; the results showed that the in situ integration efficiency of construct 1 was greatly reduced, which may be due to the short 5' end sequence of the vector, which affected the in situ integration efficiency.
[0039] Construct 2: Compared with the above-mentioned vector pHY1.0, it lacks the second promoter at the 5' end of the CotZ encoding gene; the results show that although the construct 2 can display the foreign protein molecule fused with the CotZ capsid protein, the display efficiency is low. It is speculated that the reason may be that in construct 2, the first promoter at the 5' end of the CotX encoding gene has a low efficiency in promoting the expression of the CotZ encoding gene; while in the vector of the present invention, the introduction of the second promoter enhances the expression efficiency of the CotZ encoding gene.
[0040] Construct 3: The CotB and CotG coding genes were used to replace the CotX and CotY coding genes in the above-mentioned vector pHY1.0, respectively, and their respective natural promoters in the Bacillus subtilis genome were introduced at the 5' end of the CotB and CotG coding genes; the results showed that construct 3 could not achieve the purpose of simultaneously displaying multiple foreign protein molecules in the same vector.
[0041] Compared with the above constructs 1-3, the vector pHY1.0 provided by the present invention can efficiently display multiple exogenous protein molecules at the same time. When using the vector pHY1.0 to display exogenous protein molecules, the coding genes of the exogenous protein molecules can be connected (for example, by homologous recombination or by whole gene synthesis, the connecting peptide between CotX, CotY and / or CotZ and the exogenous protein can be shown as SEQ ID NO: 11) to the 3' end of one, two or three of the CotX, CotY, CotZ coding genes in the vector pHY1.0 to construct an expression vector for the exogenous protein molecules. Subsequently, the linearized expression vector is integrated in situ into the corresponding position in the Bacillus subtilis genome through the sequence for homologous recombination in the vector pHY1.0 (for example, the sequence connected after the 3' ends of the CotW coding gene and the CotZ coding gene, etc.), and the exogenous protein molecules will be displayed on the surface of the spore particles of Bacillus subtilis in the form of fusion proteins with CotX, CotY and / or CotZ, thereby achieving the purpose of simultaneously displaying one or more exogenous protein molecules on each spore surface.
[0042] Specifically, the vector pHY1.0 is one of the following nucleotide sequences:
[0043] 1) the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing;
[0044] 2) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing and having the function of in situ integration of the CotW / X / Y / Z encoding gene in the Bacillus subtilis genome;
[0045] 3) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0046] SEQ ID NO: 1 in the sequence listing consists of 7595 bases, and its coding sequence is CotW, CotX and CotY coding gene sequences at bases 1-1585 from the 5' end, BamHI and HindIII multiple cloning sites at bases 1586-1600 from the 5' end, vector backbone and chloramphenicol resistance gene at bases 1601-2667 from the 5' end, vector backbone and CotZ coding gene sequence at bases 2668-3691 from the 5' end, genomic sequence after the 3' end of CotZ gene for homologous recombination at bases 3692-4468 from the 5' end, vector backbone, bases 4469-7595 from the 5' end, wherein bases 5766-6354 from the 5' end are plasmid replication initiation sequence, and bases 6525-7490 from the 5' end are ampicillin resistance gene. A multiple cloning site can also be inserted at the 3' end of the CotX coding gene and / or the CotZ coding gene. When the vector pHY1.0 of SEQ ID NO: 1 is used to connect the coding gene of the foreign protein molecule, the coding gene of the foreign protein molecule can be connected to the 3' end of the CotY coding gene by enzyme cutting, and the coding gene of the foreign protein molecule can be connected to the 3' end of the CotX and / or CotZ coding gene by whole gene synthesis or homologous recombination; when there are multiple cloning sites at the 3' ends of the CotX, CotY and CotZ coding genes, the coding gene of the foreign protein molecule can be connected to the 3' ends of the CotX, CotY and CotZ coding genes by enzyme cutting.
[0047] The vector pHY1.0 may also be one of the following nucleotide sequences:
[0048] 1) the nucleotide sequence shown in SEQ ID NO: 2 in the sequence listing;
[0049] 2) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 2 in the sequence list and having the function of in situ integration of the CotW / X / Y / Z encoding gene in the Bacillus subtilis genome;
[0050] 3) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 2 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0051] SEQ ID NO: 2 in the sequence listing consists of 7580 bases, and its coding sequence is that bases 1 to 1585 from the 5' end are CotW, CotX and CotY coding gene sequences, bases 1586 to 2652 from the 5' end are vector backbone and chloramphenicol resistance gene, bases 2653 to 3676 from the 5' end are vector backbone and CotZ coding gene sequence, bases 3677 to 4453 from the 5' end are genomic sequences after the 3' end of the CotZ gene for homologous recombination, bases 4454 to 7580 from the 5' end are vector backbone, wherein bases 5751 to 6339 from the 5' end are plasmid replication initiation sequence, and bases 6510 to 7475 from the 5' end are ampicillin resistance gene. When the vector pHY1.0 of SEQ ID NO: 2 is used to connect the coding gene of the foreign protein molecule, the coding gene of the foreign protein molecule can be connected to the 3' end of the CotX, CotY and / or CotZ coding gene by total gene synthesis.
[0052] 2. The vector pHY1.0 is used to construct a spore surface display vector pHY1.0 / FlaB+, and to prepare recombinant subtilis spore particles that efficiently display one or more (e.g., two or three, the same below) foreign proteins FlaB+ on the surface. The foreign protein FlaB+ is a fusion protein of Vibrio vulnificus flagellin B (FlaB), heat-labile enterotoxin B subunit (LTB) and Vibrio cholerae toxin B subunit (CTB).
[0053] Specifically, the exogenous protein FlaB+ is one of the following amino acid residue sequences:
[0054] 1) the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing;
[0055] 2) A protein having immune adjuvant activity in which one to ten amino acid residues are substituted, deleted or added to the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing.
[0056] SEQ ID NO: 3 in the sequence listing consists of 635 amino acid residues, the amino acid residues at positions 1-5 (5aa) from the amino terminus are enterokinase recognition sites, the amino acid residues at positions 6-381 (376aa) from the amino terminus are Vibrio vulnificus flagellin B (FlaB), the amino acid residues at positions 382-389 (8aa) from the amino terminus are connecting peptides, the amino acid residues at positions 390-512 (123aa) from the amino terminus are Vibrio cholerae toxin B subunit (CTB), the amino acid residues at positions 513-518 (6aa) from the amino terminus are connecting peptides, the amino acid residues at positions 519-621 (103aa) from the amino terminus are heat-labile enterotoxin B subunit (LTB), the amino acid residues at positions 622-626 (5aa) from the amino terminus are connecting peptides, and the amino acid residues at positions 627-635 (9aa) from the amino terminus are M cell binding peptides.
[0057] The gene encoding the above-mentioned exogenous protein FlaB+ also belongs to the present invention, and the gene is one of the following nucleotide sequences:
[0058] 1) the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing;
[0059] 2) a nucleotide sequence encoding the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing;
[0060] 3) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing and encoding a protein having immune adjuvant activity;
[0061] 4) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0062] SEQ ID NO: 4 in the sequence listing consists of 1908 bases, encoding a protein having the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence listing, wherein bases 1 to 15 from the 5' end encode an enterokinase recognition site, bases 16 to 1143 from the 5' end encode Vibrio vulnificus flagellin B (FlaB), bases 1144 to 1167 from the 5' end encode a connecting peptide, bases 1168 to 1536 from the 5' end encode Vibrio cholerae toxin B subunit (CTB), bases 1537 to 1554 from the 5' end encode a connecting peptide, bases 1555 to 1863 from the 5' end encode a heat-labile enterotoxin B subunit (LTB), bases 1864 to 1878 from the 5' end encode a connecting peptide, and bases 1879 to 1908 from the 5' end encode an M cell binding peptide.
[0063] 3. Use the vector pHY1.0 to construct a spore surface display vector pHY1.0 / UrB+, and prepare recombinant subtilis spore particles that efficiently display one or more foreign proteins UrB+ on the surface. The foreign protein UrB+ is a fusion protein of Helicobacter pylori urease B, heat shock protein A and LTB.
[0064] Specifically, the exogenous protein UrB+ is one of the following amino acid residue sequences:
[0065] 1) the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing;
[0066] 2) A protein having antigenic activity in which one to ten amino acid residues of the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing are replaced, deleted or added.
[0067] SEQ ID NO: 5 in the sequence listing consists of 823 amino acid residues, of which the amino acid residues at positions 1-593 (593aa) from the amino terminus are urease B, the amino acid residues at positions 594-598 (5aa) from the amino terminus are a connecting peptide, the amino acid residues at positions 599-715 (117aa) from the amino terminus are heat shock protein A, the amino acid residues at positions 716-720 (5aa) from the amino terminus are a connecting peptide, and the amino acid residues at positions 721-823 (103aa) from the amino terminus are heat-labile enterotoxin B subunit (LTB).
[0068] The gene encoding the above-mentioned exogenous protein UrB+ also belongs to the present invention, and the gene is one of the following nucleotide sequences:
[0069] 1) the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing;
[0070] 2) a nucleotide sequence encoding the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing;
[0071] 3) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing and encoding a protein having antigenic activity;
[0072] 4) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0073] SEQ ID NO: 6 in the sequence listing consists of 2469 bases, encoding a protein having the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence listing, wherein bases 1 to 1779 from the 5' end encode urease B, bases 1780 to 1794 from the 5' end encode a connecting peptide, bases 1795 to 2145 from the 5' end encode heat shock protein A, bases 2146 to 2160 from the 5' end encode a connecting peptide, and bases 2161 to 2469 from the 5' end encode heat-labile enterotoxin B subunit (LTB).
[0074] 4. Use the vector pHY1.0 to construct a spore surface display vector pHY1.0 / VacA+, and prepare recombinant subtilis spore particles that efficiently display one or more foreign proteins VacA+ on the surface. The foreign protein VacA+ is a fusion protein of Helicobacter pylori vacuolating toxin A, adhesin A and LTB.
[0075] Specifically, the exogenous protein VacA+ is one of the following amino acid residue sequences:
[0076] 1) the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing;
[0077] 2) A protein having antigenic activity in which one to ten amino acid residues of the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing are replaced, deleted or added.
[0078] SEQ ID NO: 7 in the sequence listing consists of 673 amino acid residues, of which the amino acid residues at positions 1-327 (327aa) from the amino terminus are vacuolating toxin A, the amino acid residues at positions 328-332 (5aa) from the amino terminus are a connecting peptide, the amino acid residues at positions 333-565 (233aa) from the amino terminus are adhesin A, the amino acid residues at positions 566-570 (5aa) from the amino terminus are a connecting peptide, and the amino acid residues at positions 571-673 (103aa) from the amino terminus are heat-labile enterotoxin B subunit (LTB).
[0079] The gene encoding the above-mentioned exogenous protein VacA+ also belongs to the present invention, and the gene is one of the following nucleotide sequences:
[0080] 1) the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing;
[0081] 2) a nucleotide sequence encoding the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing;
[0082] 3) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing and encoding a protein having antigenic activity;
[0083] 4) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0084] SEQ ID NO: 8 in the sequence listing consists of 2019 bases, encoding a protein having the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence listing, wherein bases 1-981 from the 5' end encode vacuolating toxin A, bases 982-996 from the 5' end encode a connecting peptide, bases 997-1695 from the 5' end encode adhesin A, bases 1696-1710 from the 5' end encode a connecting peptide, and bases 1711-2019 from the 5' end encode a heat-labile enterotoxin B subunit (LTB).
[0085] 5. Use the vector pHY1.0 to construct a spore surface display vector pHY1.0 / CdTA+, and prepare recombinant subtilis spore particles with efficient surface display of one or more exogenous proteins CdTA+. The exogenous protein CdTA+ is a fusion protein of FlaB, the carboxyl terminal receptor binding domain of Clostridium difficile toxin A, and LTB.
[0086] Specifically, the exogenous protein CdTA+ is one of the following amino acid residue sequences:
[0087] 1) the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing;
[0088] 2) A protein having antigenic activity in which one to ten amino acid residues of the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing are replaced, deleted or added.
[0089] SEQ ID NO: 9 in the sequence listing consists of 831 amino acid residues, the amino acid residues at positions 1-5 (5aa) from the amino terminus are enterokinase recognition sequence, the amino acid residues at positions 6-381 (376aa) from the amino terminus are Vibrio vulnificus flagellin B (FlaB), the amino acid residues at positions 382-389 (8aa) from the amino terminus are a connecting peptide, the amino acid residues at positions 390-708 (319aa) from the amino terminus are Clostridium difficile toxin A carboxyl terminal receptor binding domain, the amino acid residues at positions 709-714 (6aa) from the amino terminus are a connecting peptide, the amino acid residues at positions 715-817 (103aa) from the amino terminus are heat-labile enterotoxin B subunit (LTB), the amino acid residues at positions 818-822 (5aa) from the amino terminus are a connecting peptide, and the amino acid residues at positions 823-831 (9aa) from the amino terminus are an M cell binding peptide.
[0090] The gene encoding the above-mentioned exogenous protein CdTA+ also belongs to the present invention, and the gene is one of the following nucleotide sequences:
[0091] 1) the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing;
[0092] 2) a nucleotide sequence encoding the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing;
[0093] 3) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing and encoding a protein having antigenic activity;
[0094] 4) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing under highly stringent conditions, wherein the membrane is washed with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
[0095] SEQ ID NO: 10 in the sequence listing consists of 2493 bases, encoding a protein having the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence listing, wherein bases 1 to 15 from the 5' end encode the enterokinase recognition sequence, bases 16 to 1143 from the 5' end encode Vibrio vulnificus flagellin B (FlaB), bases 1144 to 1167 from the 5' end encode the connecting peptide, bases 1168 to 2124 from the 5' end encode the carboxyl-terminal receptor binding domain of Clostridium difficile toxin A, bases 2125 to 2451 from the 5' end encode the heat-labile enterotoxin B subunit (LTB), bases 2452 to 2466 from the 5' end encode the connecting peptide, and bases 2467 to 2493 from the 5' end encode the M cell binding peptide.
[0096] 6. The vector pHY1.0 is used to construct recombinant subtilis spore particles that can efficiently display any one, two or three of Vibrio vulnificus flagellin B (FlaB), heat-labile enterotoxin B subunit (LTB), Vibrio cholerae toxin B subunit (CTB), Helicobacter pylori urease B, Helicobacter pylori heat shock protein A, Helicobacter pylori vacuolating toxin A, Helicobacter pylori adhesin A, Clostridium difficile toxin A and Clostridium difficile toxin B on the spore surface.
[0097] The present invention is further described in detail below in conjunction with specific examples. The construction of all spore surface display vectors refers to or refers to the method of Example 1, and the preparation of recombinant subtilis spore particles displaying fusion proteins on the surface refers to or refers to Example 3.
[0098] The disclosure below provides many different implementations or examples for realizing different aspects of the present invention. The methods for obtaining various biological materials described in the examples only provide an experimental method for obtaining the materials to achieve the specific disclosed purpose, and should not be a limitation on the source of the biological materials of the present invention. In fact, the sources of the biological materials used are extensive, and any biological materials that can be obtained without violating laws and moral ethics can be replaced and used according to the instructions in the examples; in industrial implementation, various cells derived from mammals such as rats, mice, pigs or humans are in vitro, and include those obtained from cell banks or purchased commercially, as well as those prepared according to the introduction of existing literature, and those induced by known methods using a variety of commercially available stem cells.
[0099] The methods used in the following examples are all conventional methods unless otherwise specified. For specific steps, please refer to: "Molecular Cloning: A Laboratory Manual" (Sambrook, J., Russell, David W., Molecular Cloning: A Laboratory Manual, 3rd edition, 2001, NY, Cold Spring Harbor).
[0100] The present invention is described in detail with specific examples below. The examples are implemented based on the technical solution of the present invention, and provide detailed implementation methods and specific operation processes, but the disclosure of the present invention is not limited to the following examples.
[0101] Example 1: Construction of spore surface display vector
[0102] The construction of all expression vectors in this example, including pHY1.0 (SEQ ID NO: 1 and SEQ ID NO: 2), pHY1.0 / FlaB+, pHY1.0 / UrB+, pHY1.0 / VacA+, pHY1.0 / CdTA+, pHY1.0 / FlaB+ / FlaB+ / FlaB+ and pHY1.0 / FlaB / LTB / CTB, was completed by Nanjing GenScript Biotech Co., Ltd. Wherein: for the pHY1.0 / FlaB+ expression vector, the coding gene of the exogenous protein FlaB+ is connected to the 3' end of the CotX coding gene in pHY1.0 (SEQ ID NO: 2); for the pHY1.0 / UrB+ expression vector, the coding gene of the exogenous protein UrB+ is connected to the 3' end of the CotX coding gene in pHY1.0 (SEQ ID NO: 2); for the pHY1.0 / VacA+ expression vector, the coding gene of the exogenous protein VacA+ is connected to the 3' end of the CotY coding gene in pHY1.0 (SEQ ID NO: 1); for the pHY1.0 / CdTA+ expression vector, the coding gene of the exogenous protein CdTA+ is connected to the 3' end of the CotZ coding gene in pHY1.0 (SEQ ID NO: 2); for the pHY1.0 / FlaB+ / FlaB+ / FlaB+ expression vector, the coding gene of the exogenous protein FlaB+ is connected to the 3' end of the CotY coding gene in pHY1.0 (SEQ ID NO: 2); NO:2), so that the pHY1.0 / FlaB+ / FlaB+ / FlaB+ expression vector can simultaneously express and display three exogenous proteins FlaB+; for the pHY1.0 / FlaB / LTB / CTB expression vector, the coding gene of the exogenous protein FlaB is connected to the 3' end of the CotX coding gene in pHY1.0 (SEQ ID NO:1), the coding gene of the exogenous protein LTB is connected to the 3' end of the CotY coding gene in pHY1.0, and the coding gene of the exogenous protein CTB is connected to the 3' end of the CotZ coding gene in pHY1.0, so that the pHY1.0 / FlaB / LTB / CTB expression vector can simultaneously express and display three different exogenous proteins: FlaB, LTB and CTB.
[0103] Before transformation, the above-constructed vector plasmids (pHY1.0, pHY1.0 / FlaB+, pHY1.0 / UrB+, pHY1.0 / VacA+, pHY1.0 / CdTA+, pHY1.0 / FlaB+ / FlaB+ / FlaB+ and pHY1.0 / FlaB / LTB / CTB) were first linearized. The specific operation method was as follows: 50 μl enzyme digestion system was used: 5 μl 10×NEB enzyme digestion buffer 2.1, 10 μl vector plasmid (1 μg / μl), 1 μl NEB EcoRI enzyme, 34 μl deionized water, and enzyme digestion was carried out at 37°C for 3 hours. Add 5 μl 3M sodium acetate and 150 μl anhydrous ethanol, mix well and place at -80℃ for 1 hour, then centrifuge at 12000rpm for 10 minutes. Add 1ml 70% ethanol to the DNA precipitate, wash twice at 12000rpm for 5 minutes, dry the DNA precipitate at 37℃ for 10 minutes, and then dissolve in 20 μl sterile deionized water for use.
[0104] Example 2. Preparation and transformation of competent cells of Bacillus subtilis PY79
[0105] Prepare solutions: 100×CAYE, SP-A solution (0.4% (NH4)2SO4, 2.8% K2HPO4·3H2O, 1.2% KH2PO4, 0.2% sodium citrate), SP-B solution (0.04% MgSO4·7H2O); SPI medium (20 ml): SP-A solution 9.8 ml, SP-B solution 9.8 ml, 50% glucose solution 200μl, 100×CAYE 200μl; SPII medium (6 ml): SPI medium 5.88 ml, 50mM CaCl2 60μl, 250mM MgCl2 60μl; 100×EGTA solution: 10mM EGTA solution, add a small amount of NaOH to pH 8.0.
[0106] Preparation and transformation method of competent state of Bacillus subtilis PY79: take Bacillus subtilis glycerol bacteria and streak LB plate, culture at 37℃ overnight; pick single colony to 3ml LB medium, culture at 37℃, 250 rpm overnight; take 160μl culture solution and transfer to 8ml SPI medium, culture at 37℃, 250 rpm for 4-5 hours to the end of logarithmic growth; take 0.2ml culture solution grown to the end of logarithmic phase to 2ml SPII medium, culture at 37℃, 100rpm for 90 minutes; add 20μl 10mM EGTA to the bacteria in the above SPII medium, and culture at 37℃, 100rpm for 10 minutes; divide the above treated bacterial solution into 0.5ml per tube, add 5μl linearized vector plasmid DNA prepared in Example 1, and culture at 37℃, 250 rpm for 90 minutes. Plate.
[0107] Example 3: Preparation of recombinant Bacillus subtilis spore particles displaying fusion protein on the surface
[0108] Single colonies from the culture plates in Example 2 were picked up and placed in 10 ml of LB medium containing the corresponding antibiotics, and cultured overnight at 37°C and 200 rpm; then the colonies were transferred to 1 L of DSM medium at a ratio of 1:100 and cultured for 72 hours at 37°C and 200 rpm; the cells were collected by centrifugation at 6000 rpm for 10 minutes and resuspended in 20 ml of 10 mM Lysozyme was added to a TrisCl (pH 8.0) buffer to a final concentration of 1 mg / ml and digested at 37°C for 1 hour; the bacterial precipitate was collected by centrifugation at 6000 rpm for 10 minutes, and washed once with 1 M potassium chloride and 1 M sodium chloride, and washed three times with sterile deionized water, and finally resuspended in 10 ml of PBS to obtain recombinant subtilis spore particle suspensions that can express and display the corresponding exogenous protein molecules: pHY1.0 spore particle suspension (as a blank control), pHY1.0 / FlaB+ spore particle suspension, pHY1.0 / UrB+ spore particle suspension, pHY1.0 / VacA+ spore particle suspension, pHY1.0 / CdTA+ spore particle suspension, pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particle suspension and pHY1.0 / FlaB / LTB / CTB spore particle suspension.
[0109] Example 4: Immunofluorescence detection of exogenous proteins displayed on spore surfaces
[0110] In view of the fact that all the exogenous proteins expressed by the pHY1.0 / FlaB+ spore particles, pHY1.0 / UrB+ spore particles, pHY1.0 / VacA+ spore particles, pHY1.0 / CdTA+ spore particles and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles prepared in Example 3 contain heat-labile enterotoxin B subunit (LTB), the LTB in the exogenous protein is detected by immunofluorescence to reflect the expression and display of the exogenous proteins on the surface of the above spore particles. As for the display of exogenous proteins on the surface of pHY1.0 / FlaB / LTB / CTB spore particles, the exogenous protein FlaB, the exogenous protein LTB, and the exogenous protein CTB are detected by immunofluorescence, respectively. Specifically, the following operations are included.
[0111] Take 1 ml of the spore particle suspension prepared in Example 3 above, add BSA with a final concentration of 3% and block at room temperature for 1 hour; dilute the primary antibody with PBS containing 3% BSA (when detecting LTB, use mouse anti-LTB monoclonal antibody, 1:100; when detecting CTB, use mouse anti-CTB monoclonal antibody, 1:100; when detecting FlaB, use mouse anti-FlaB monoclonal antibody, 1:100), and incubate overnight at 2-8°C; wash three times with PBS, 5 minutes each time; add the corresponding FITC-labeled goat anti-mouse secondary antibody, incubate at room temperature for 60 minutes; wash three times with PBS, 5 minutes each time; resuspend in an appropriate volume of PBS, smear and observe under a fluorescence microscope.
[0112] The results are as follows Figure 1-5 As shown, where: Figure 1 Panels A and B in the middle represent the display of exogenous proteins on the surface of pHY1.0 / FlaB+ spore particles and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles, respectively. It can be seen that bright fluorescence was observed on the surface of pHY1.0 / FlaB+ spore particles and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles, and compared with the fluorescence quantity and brightness observed on the surface of pHY1.0 / FlaB+ spore particles, pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles showed a bright fluorescence. The number of fluorescence observed on the surface of pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles was greater and the brightness was higher, indicating that both pHY1.0 / FlaB+ spore particles and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles can display foreign protein molecules on the spore surface, and pHY1.0 / FlaB+ / FlaB+ / FlaB+ spore particles can display multiple identical foreign protein molecules at the same time, thereby increasing the abundance of foreign proteins on the spore surface; Figure 2-Figure 4 The figures respectively represent the display of foreign proteins on the surface of pHY1.0 / UrB+ spore particles, pHY1.0 / VacA+ spore particles and pHY1.0 / CdTA+ spore particles. It can be seen that bright fluorescence is observed on the surface of the above three types of spore particles, indicating that the above three types of spore particles can also display foreign protein molecules on the spore surface; Figure 5 The middle AC frames represent the display of exogenous proteins FlaB, LTB and CTB on the surface of pHY1.0 / FlaB / LTB / CTB spore particles, respectively. It can be seen that fluorescence representing exogenous proteins FlaB, LTB and CTB can be detected on the surface of pHY1.0 / FlaB / LTB / CTB spore particles, indicating that pHY1.0 / FlaB / LTB / CTB spore particles can display multiple different exogenous protein molecules at the same time, and thus multiple different exogenous protein molecules can be obtained at the same time, which is conducive to the production of multivalent vaccine antigens.
[0113] Finally, it should be noted that the above is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall belong to the content of the present invention.
Claims
1. A Bacillus subtilis genome in situ integrated spore surface display vector, named pHY1.0, characterized in that: The in situ integrated spore surface display vector pHY1.0 includes CotW, CotX, CotY and CotZ encoding genes, and is capable of simultaneously displaying multiple exogenous protein molecules, wherein the multiple exogenous protein molecules are the same or different; In the in situ integrated spore surface display vector pHY1.0, the 5' end of the CotX encoding gene contains a first promoter, and the 5' end of the CotZ encoding gene contains a second promoter; In the in situ integrated spore surface display vector pHY1.0, the CotW encoding gene is used for homologous recombination with the corresponding sequence in the Bacillus subtilis genome, and the CotX, CotY and CotZ encoding genes are used as vectors of the encoding genes of foreign protein molecules.
2. The in situ integrated spore surface display vector pHY1.0 according to claim 1, characterized in that: The first promoter and the second promoter are both natural promoters of the CotX, CotY and CotZ encoding genes in the genome sequence of Bacillus subtilis.
3. The in situ integrated spore surface display vector pHY1.0 according to claim 1 or 2, characterized in that: The in situ integrated spore surface display vector pHY1.0 also includes a pBR322 backbone, a chloramphenicol resistance gene and a penicillin resistance gene.
4. The in situ integrated spore surface display vector pHY1.0 according to claim 3, characterized in that: The 3' end of the CotW encoding gene is connected to the 5' end of the CotX encoding gene, the 3' end of the CotX encoding gene is directly connected to the 5' end of the CotY encoding gene or indirectly connected through a first multiple cloning site, the 3' end of the CotY encoding gene is separated from the 5' end of the CotZ encoding gene by an optional second multiple cloning site, a partial backbone sequence and a chloramphenicol resistance gene, and the 3' end of the CotZ encoding gene is connected to an optional third multiple cloning site, and a sequence including a sequence for homologous recombination with a corresponding sequence in the genome of Bacillus subtilis, a plasmid replication initiation sequence and a penicillin resistance gene, wherein the first multiple cloning site, the second multiple cloning site and the third multiple cloning site sequences are the same or different; Optionally, the in situ integrated spore surface display vector pHY1.0 contains one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 1; 2) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 1 and having the function of in situ integration of the CotW / X / Y / Z gene in the Bacillus subtilis genome; 3) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 1 in the sequence listing under highly stringent conditions; the highly stringent conditions are washing the membrane with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization; 4) the nucleotide sequence shown in SEQ ID NO: 2; 5) a nucleotide sequence having more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 2 and having the function of in situ integration of CotW / X / Y / Z gene in the Bacillus subtilis genome; 6) A nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 2 in the sequence listing under highly stringent conditions; the highly stringent conditions are washing the membrane with a solution containing 0.1×SSPE (or 0.1×SSC) and 0.1% SDS at 65°C after hybridization.
5. The in situ integrated spore surface display vector pHY1.0 according to any one of claims 1 to 4, characterized in that: The exogenous protein molecule is selected from: Vibrio vulnificus flagellin B (FlaB), heat-labile enterotoxin B subunit (LTB), Vibrio cholerae toxin B subunit (CTB), Helicobacter pylori urease B, Helicobacter pylori heat shock protein A, Helicobacter pylori vacuolating toxin A, Helicobacter pylori adhesin A, Clostridium difficile toxin A, Clostridium difficile toxin B, and their fusion proteins.
6. The in situ integrated spore surface display vector pHY1.0 according to claim 5, characterized in that: The exogenous protein molecule is a fusion protein of FlaB, LTB and CTB, named as exogenous protein FlaB+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence list; 2) the amino acid residue sequence shown in SEQ ID NO: 3 in the sequence list is replaced, deleted or added with one to ten amino acid residues and has an amino acid residue sequence with immune adjuvant activity; Optionally, the nucleotide sequence of the gene encoding the exogenous protein FlaB+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 3 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing and encodes an immune adjuvant molecule; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 4 in the sequence listing under highly stringent conditions.
7. The in situ integrated spore surface display vector pHY1.0 according to claim 5, characterized in that: The exogenous protein molecule is a fusion protein of Helicobacter pylori urease B, heat shock protein A and LTB, named as exogenous protein UrB+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence list; 2) an amino acid residue sequence having antigenic activity after one to ten amino acid residues are substituted, deleted or added to the amino acid residue sequence shown in SEQ ID NO: 5 in the sequence list; Optionally, the nucleotide sequence of the gene encoding the exogenous protein UrB+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 5 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 6 in the sequence listing under highly stringent conditions.
8. The in situ integrated spore surface display vector pHY1.0 according to claim 5, characterized in that: The exogenous protein molecule is a fusion protein of Helicobacter pylori vacuolating toxin A, adhesin A and LTB, named as exogenous protein VacA+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence list; 2) the amino acid residue sequence shown in SEQ ID NO: 7 in the sequence list is replaced, deleted or added with one to ten amino acid residues and has an amino acid residue sequence with antigenic activity; Preferably, the nucleotide sequence of the gene encoding the exogenous protein VacA+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 7 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 8 in the sequence listing under highly stringent conditions.
9. The in situ integrated spore surface display vector pHY1.0 according to claim 5, characterized in that: The exogenous protein molecule is a fusion protein of FlaB, Clostridium difficile toxin A and LTB, named as exogenous protein CdTA+, and its amino acid residue sequence is one of the following amino acid residue sequences: 1) the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence list; 2) the amino acid residue sequence shown in SEQ ID NO: 9 in the sequence list is replaced, deleted or added with one to ten amino acid residues and has an amino acid residue sequence with antigenic activity; Optionally, the nucleotide sequence of the gene encoding the exogenous protein CdTA+ is one of the following nucleotide sequences: 1) the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing; 2) the nucleotide sequence encoding SEQ ID NO: 9 in the sequence listing; 3) a nucleotide sequence that has more than 90% homology with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing and encodes an antigen; 4) a nucleotide sequence that can hybridize with the nucleotide sequence shown in SEQ ID NO: 10 in the sequence listing under highly stringent conditions.
10. Use of the in situ integrating spore surface display vector pHY1.0 according to any one of claims 1 to 9 in the development or production of a multivalent vaccine.
Citation Information
Cited By
Recombinant bacillus subtilis for displaying fusion protein of edwardsiella tarda outer membrane protein OmpA and vibrio cholerae enterotoxin CTB on surface, construction method and application
CN119614471A
Recombinant bacillus subtilis displaying on surface fusion protein of edwardsiella tarda outer membrane protein ompa and vibrio cholerae enterotoxin ctb, construction method and application
CN119614471B
